| Literature DB >> 22187649 |
Shailaja Moodithaya1, Sandhya T Avadhany.
Abstract
Ageing is associated with changes in cardiac autonomic control as measured by Heart Rate Variability (HRV). Not many studies have explored the influence of gender on age-related changes in cardiac autonomic regulation. This study evaluated the gender differences in age-associated changes in cardiac autonomic nervous activity by assessing HRV using frequency domain analysis of short-term stationary R-R intervals. HRV was studied in healthy males and females ranging in age from 6 to 55 years. Total power and absolute power in High-Frequency (HF) and Low-Frequency (LF) components as well as HF in normalized unit declined significantly with ageing. The HF/LF ratio was significantly higher in the adolescent and adult females compared to male of these age groups. This study suggests that gender differences exist in age-related changes in HRV. The finding that gender differences are limited to adolescent and adult age groups may indicate a role for female sex hormones in cardiac autonomic modulation.Entities:
Year: 2011 PMID: 22187649 PMCID: PMC3236491 DOI: 10.1155/2012/679345
Source DB: PubMed Journal: J Aging Res ISSN: 2090-2204
Subject characteristics.
| Parameter | Children | Adolescents | Young adults | Middle-aged | ||||
|---|---|---|---|---|---|---|---|---|
| Males | Females | Males | Females | Males | Females | Males | Females | |
| ( | ( | ( | ( | ( | ( | ( | ( | |
| Age (yrs) | 9.4 ± 0.32 | 9.4 ± 0.3 | 17.0 ± 0.38 | 16.4 ± 0.38 | 29 ± 0.8 | 30.1 ± 0.86 | 48.3 ± 0.6 | 48.5 ± 0.64 |
| Height (cm) | 131 ± 1.98 | 130 ± 1.9 | 159 ± 5.1 | 154 ± 0.78 | 166 ± 1 | 156 ± 0.8 | 167 ± 3.8 | 155 ± 0.78 |
| Weight (kg)* | 27 ± 1.2 | 26.4 ± 1.9 | 55.5 ± 1.9 | 49.0 ± 1.1 | 59.4 ± 1.3 | 53.1 ± 0.95 | 58.9 ± 1.3 | 56.1 ± 0.9 |
| SBP∗# | 112 ± 1.6 | 108 ± 1.3 | 114 ± 2.3 | 109 ± 1.1 | 116 ± 1.1 | 111 ± 6.8 | 120 ± 1.66 | 118 ± 1.73 |
| DBP∗# | 74 ± 1.4 | 74 ± 0.76 | 76 ± 0.8 | 75 ± 0.7 | 78 ± 0.8 | 76 ± 0.7 | 84 ± 1.1 | 81 ± 1.2 |
| RHR* | 78 ± 1.8 | 82 ± 1.7 | 67 ± 1.96 | 69 ± 1.1 | 64 ± 1.7 | 67 ± 1.1 | 69 ± 1.96 | 66 ± 1.3 |
| BMI* | 15.5 ± 0.24 | 15.6 ± 0.22 | 20.5 ± 0.36 | 20.5 ± 0.37 | 21.6 ± 0.33 | 21.7 ± 0.33 | 22.1 ± 0.3 | 23.1 ± 0.3 |
| PAL | N.A@ | N.A@ | 1.64 ± 0.02 | 1.59 ± 0.02 | 1.6 ± 0.02 | 1.65 ± 0.02 | 1.65 ± 0.02 | 1.69 ± 0.02 |
(i) Data expressed as mean ± SE.
(ii) *significantly different across the age group.
(iii) #significantly different between males and females.
(iv) SBP: Systolic blood pressure (mm of Hg).
(v) DBP: Diastolic blood pressure (mm of Hg).
(vi) RHR: Resting heart rate (Beats per minute).
(vii) BMI: Body Mass Index (kg/m2).
(viii) PAL: Physical activity level.
(ix) @Not applicable since standard procedure was not available.
Comparison of heart rate variability spectral power (absolute power) in males and females of different age groups (n = 252).
| Children | Adolescent | Young adults | Middle-aged | |
|---|---|---|---|---|
| Total power (0–0.4 Hz) (ms2) | ||||
| Males | 2694 ± 336 | 2072 ± 306 | 1171 ± 212 | 563 ± 121 |
| (2006–3381) | (1446–2697) | (736–1606) | (313–814) | |
| Females | 2433 ± 331 | 1612 ± 246 | 1148 ± 149 | 478 ± 82 |
| (1756–3110) | (1112–2112) | (846–1456) | (308–448) | |
| Total | 2564 ± 234 | 1822 ± 194 | 1158 ± 124∗† | 520 ± 72∗†‡ |
| (2094–3033) | (1434–2209) | (909–1407) | (375–665) | |
|
| ||||
| Two-way ANOVA: | ||||
|
| ||||
| High-frequency power (0.15–0.4 Hz) (ms2) | ||||
| Males | 1645 ± 209 | 1057 ± 165 | 533 ± 98 | 238 ± 56 |
| (1215–2074) | (720–1394) | (331–734) | (121–355) | |
| Females | 1561 ± 254 | 999 ± 155 | 628 ± 98 | 209 ± 56 |
| (1040–2082) | (683–1314) | (427–825) | (128–289) | |
| Total | 1603 ± 163 | 1025 ± 112 | 585 ± 69∗† | 223 ± 34∗†‡ |
| (1250–1931) | (801–1275) | (446–724) | (155–291) | |
|
| ||||
| Two-way ANOVA: | ||||
|
| ||||
| Low-frequency power (0.04–0.15 Hz) (ms2) | ||||
| Males | 1049 ± 148 | 1001 ± 187 | 638 ± 118 | 325 ± 66 |
| (745–1352) | (619–1384) | (396–879) | (188–461) | |
| Females | 872 ± 108 | 584 ± 111 | 522 ± 71 | 269 ± 45 |
| (650–1093) | (357–812) | (377–666) | (175–363) | |
| Total | 960 ± 92 | 760 ± 103 | 573 ± 65∗† | 296 ± 39∗†‡ |
| (776–1144) | (583–997) | (442–703) | (217–376) | |
|
| ||||
| Two-way ANOVA: | ||||
Data expressed as mean ± SEM and 95% Confidence Intervals.
*Significantly different from children group.
†Significantly different from adolescent age group.
‡Significantly different from adult group.
#Significantly different from females of same age group.
≠Age × Gender = age and gender interaction.
Figure 1The figure shows that age-related decline of HF nu across four age groups in both males and females as well as gender-related difference in adolescent age group. *Significantly different from children group; #Significantly different from adult group. $Significantly different from males using two-way ANOVA.
Figure 2The figure shows ratio of HF to LF ratio across four age groups in males and females. It depicts the age-related decline in HF/LF ratio in males and females. Females have significantly higher HF/LF ratio as compared to males in the adolescent and adult groups. In the two extreme of ages the ratio is almost similar; *significantly different from children group; #significantly different from adult group; $Significantly different from males of similar age group using two-way ANOVA.